Finance: Novartis shares dropped nearly 10% following three setbacks in drug trials, marking the company's worst trading day on record.
Novartis shares plummeted on Tuesday following disappointing results from their del-desiran drug trial, leaving investors concerned. Stay tuned for updates on how this may impact the company moving forward! #Novartis #PharmaNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
